The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Increased Premature Mortality of Competitive Powerlifters Suspected to Have Used Anabolic Agents
Abstract
Misuse of supraphysiological doses of anabolic steroids is claimed to have serious side effects. The aim of the study was to determine the mortality, and the cause of premature deaths among a group of subjects who are strongly suspected to have used anabolic steroids for a non-medical purpose over several years. The mortality of 62 male powerlifters placed 1st-5th in weight series 82.5-125 kg in Finnish championships during 1977-1982 was compared with the mortality of population controls. The mortality during the 12-year follow-up was 12.9% for the powerlifters compared to 3.1% in the control population. By 1993 eight of 62 powerlifters and 34 of 1094 population controls had died, thus the risk of death among the powerlifters was 4.6 times higher (95% CI 2.04-10.45; p = 0.0002). The causes of premature death among the powerlifters were suicide (3), acute myocardial infarction (3), hepatic coma (1) and non-Hodgkin's lymphoma (1). These findings add to the growing amount of evidence of an association between anabolic steroid abuse and premature death, and support the view that measures to decrease AAS misuse among both competitive and amateur athletes are justified.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Paffenbarger, R. S., Hyde, R. T., Wing, A. L., Lee, I.-M., Jung, D. L., & Kampert, J. B. (1993) · New England Journal of Medicine · doi:10.1056/nejm199302253280804 · Cited by 1,972
Indications of prevalence, practice and effects of anabolic steroid use in Great Britain.
Korkia, P., & Stimson, G. (1997) · International Journal of Sports Medicine · doi:10.1055/s-2007-972681 · Cited by 143
Cited by
Effects of Androgenic-Anabolic Steroids in Athletes
Hartgens, F., & Kuipers, H. (2004) · Sports Medicine · doi:10.2165/00007256-200434080-00003 · Cited by 873
Androgens and Cardiovascular Disease
Liu, P. Y., Death, A. K., & Handelsman, D. J. (2003) · Endocrine Reviews · doi:10.1210/er.2003-0005 · Cited by 695
Pope, H. G., Wood, R. I., Rogol, A., Nyberg, F., Bowers, L., & Bhasin, S. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1058 · Cited by 658
Kanayama, G., Hudson, J. I., & Pope, H. G. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.05.004 · Cited by 404
Current Concepts in Anabolic-Androgenic Steroids
Evans, N. A. (2004) · The American Journal of Sports Medicine · doi:10.1177/0363546503262202 · Cited by 379
Use of doping agents, particularly anabolic steroids, in sports and society
Sjöqvist, F., Garle, M., & Rane, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60801-6 · Cited by 351
Pope, H. G., Kanayama, G., Athey, A., Ryan, E., Hudson, J. I., & Baggish, A. (2014) · The American Journal on Addictions · doi:10.1111/j.1521-0391.2013.12118.x · Cited by 306
Adverse health effects of anabolic–androgenic steroids
van Amsterdam, J., Opperhuizen, A., & Hartgens, F. (2010) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2010.02.001 · Cited by 286
Are the cardiac effects of anabolic steroid abuse in strength athletes reversible?
Urhausen, A., Albers, T., & Kindermann, W. (2004) · Heart · doi:10.1136/hrt.2003.015719 · Cited by 275
Achar, S., Rostamian, A., & Narayan, S. M. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.05.013 · Cited by 265
Endocrine Aspects of Male Sexual Dysfunctions
Buvat, J., Maggi, M., Gooren, L., Guay, A. T., Kaufman, J., Morgentaler, A., Schulman, C., Tan, H. M., Torres, L. O., Yassin, A., et al. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01780.x · Cited by 221
Health consequences of androgenic anabolic steroid use
Horwitz, H., Andersen, J. T., & Dalhoff, K. P. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12850 · Cited by 204
Belli, S., & Vanacore, N. (2005) · European Journal of Epidemiology · doi:10.1007/s10654-004-6879-7 · Cited by 140
Do elite athletes live longer? a systematic review of mortality and longevity in elite athletes.
Lemez, S., & Baker, J. (2015) · Sports Medicine - Open · doi:10.1186/s40798-015-0024-x · Cited by 117
“whereas the lowest LEs were found in Finnish powerlifters [53].”
BackgroundInfluentialDoping in sport: effects, harm and misconceptions
Birzniece, V. (2015) · Internal Medicine Journal · doi:10.1111/imj.12629 · Cited by 99
Chronic traumatic encephalopathy and risk of suicide in former athletes
Iverson, G. L. (2014) · British Journal of Sports Medicine · doi:10.1136/bjsports-2013-092935 · Cited by 90
National Athletic Trainers' Association Position Statement: Anabolic-Androgenic Steroids
Kersey, R. D., Elliot, D. L., Goldberg, L., Kanayama, G., Leone, J. E., Pavlovich, M., & Pope, H. G. (2012) · Journal of Athletic Training · doi:10.4085/1062-6050-47.5.08 · Cited by 73
Illicit drugs and cardiac arrhythmias in athletes
Furlanello, F., Serdoz, L. V., Cappato, R., & De Ambroggi, L. (2007) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e3280ecfe3e · Cited by 70
Metadata
- Authors
- Pärssinen, M., Kujala, U., Vartiainen, E., Sarna, S., & Seppälä, T.
- Venue
- International Journal of Sports Medicine
- Publisher
- Georg Thieme Verlag KG
- Published
- 2000-04
- Volume
- 21
- Issue
- 3
- Pages
- 225-227
- ISSN
- 0172-4622 (ISSN-L)
- 1439-3964
- OpenAlex
- W2004557805
- Cited by
- 199
- References
- 2
- FWCI
- 20.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.